共 91 条
[1]
Perloff M(1982)Chemotherapy before and after mastectomy in stage III breast cancer Arch Surg 117 879-616
[2]
Lesnick GJ(1997)Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18 J Clin Oncol 15 2483-382
[3]
Fisher B(2008)Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 J Clin Oncol 26 778-3474
[4]
Brown A(2014)Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (alliance) prospective multicenter clinical trial Ann Surg 260 608-551
[5]
Mamounas E(2015)Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure Ann Surg 261 378-3630
[6]
Rastogi P(2016)How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastasis? Results of a prospective study Ann Surg Oncol 23 3467-2972
[7]
Anderson SJ(2016)Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3398 patients Am J Surg 212 969-2441
[8]
Bear HD(2008)Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GerparTrio trial J Natl Cancer Inst 100 542-172
[9]
Boughey JC(2013)Response-guided neoadjuvant chemotherapy for breast cancer J Clin Oncol 31 3623-201
[10]
McCall LM(2013)Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer Br J Cancer 109 2965-2248